Open AccessP1636: PATIENT PREFERENCES AND EXPERIENCES REGARDING THROMBOPOIETIN‐RECEPTOR AGONISTS FOR IMMUNE THROMBOCYTOPENIA IN THE NETHERLANDS (TRAPEZE NL STUDY).
Author(s) -
Jansen A. G.,
McDonald V.,
Newland A.,
Morgan M.,
VisserPeereboom S.,
Wilson K.,
Eriksson D.,
Geldman E.,
DaykinPont O.,
Zwaginga J. J.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849400.99937.5f
Subject(s) - medicine , thrombopoietin receptor , romiplostim , thrombopoietin , immune thrombocytopenia , dosing , patient satisfaction , pediatrics , platelet , surgery , genetics , stem cell , haematopoiesis , biology